Michael Shalmi
Chairman at ACTIVE BIOTECH AB
Network origin in Michael Shalmi first degree
Entity | Entity type | Industry | |
---|---|---|---|
29
| Public Company | Pharmaceuticals: Major | 29 |
Novo Principal Investments
Novo Principal Investments Investment ManagersFinance Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark.
26
| Operating Division | Investment Managers | 26 |
Novo Holdings AS (Denmark)
Novo Holdings AS (Denmark) Financial ConglomeratesFinance Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark.
17
| Subsidiary | Financial Conglomerates | 17 |
Public Company | Biotechnology | 12 | |
Momentum Gruppen A/S
Momentum Gruppen A/S Electric UtilitiesUtilities Momentum Gruppen A/S provides and administrates solar and wind projects. It specializes in procuring, disseminating, and managing solar and wind projects. The firm assists in planning, construction, operational, asset life extension, repowering, decommissioning, and sales and sourcing of projects. The company was founded by Kim Madsen in 2005 and is headquartered in Roskilde, Denmark.
4
| Private Company | Electric Utilities | 4 |
Env Holdcoco AS
Env Holdcoco AS Financial ConglomeratesFinance Env Holdcoco AS is an investment holding Danish company.
1
| Private Company | Financial Conglomerates | 1 |
Sonion Holdco A/S
Sonion Holdco A/S Financial ConglomeratesFinance Part of Sonion A/S, Sonion Holdco A/S is an investment holding Danish company. The company is based in Hellerup, Denmark.
1
| Subsidiary | Financial Conglomerates | 1 |
Xellia Holdco A/S
1
| Private Company | 1 | |
Momentum Energy Karrebæk Holding K/S
Momentum Energy Karrebæk Holding K/S Financial ConglomeratesFinance Momentum Energy Karrebæk Holding K/S is an investment holding private company based in Roskilde, Denmark. and has subsidiaries in Denmark. Momentum Energy Karrebæk Holding K/S functions as an investment holding Danish company. The company was founded in 2021 and the CEO is Kim Madsen.
1
| Private Company | Financial Conglomerates | 1 |
Momentum Energy Group A/S
Momentum Energy Group A/S Electric UtilitiesUtilities Momentum Energy Group A/S is a holding Danish company that provides electricity production services. The private company is based in Roskilde, Denmark and has subsidiaries in Denmark. The CEO of the company is Michael Shalmi.
1
| Private Company | Electric Utilities | 1 |
Novo Invest 1 A/S
Novo Invest 1 A/S Financial ConglomeratesFinance Novo Invest 1 A/S provides investment services. The private company is based in Hellerup, Denmark.
1
| Private Company | Financial Conglomerates | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael Shalmi via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
NOVO NORDISK A/S | Pharmaceuticals: Major | Director/Board Member Public Communications Contact Chairman Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Director/Board Member Director/Board Member Director of Finance/CFO Corporate Officer/Principal Director/Board Member | |
Stockholm School of Economics | College/University | Undergraduate Degree Graduate Degree Graduate Degree Masters Business Admin Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
Novo Holdings A/S (Investment Company)
Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Director of Finance/CFO Chairman Director/Board Member Chief Executive Officer Corporate Officer/Principal Chief Investment Officer Director/Board Member | |
Novo Ventures 1 A/S
Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Chairman Chief Investment Officer Private Equity Investor Private Equity Investor Director of Finance/CFO Corporate Officer/Principal Chief Executive Officer | |
Copenhagen Business School | College/University | Undergraduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
Biolipox AB
Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Chairman Chief Tech/Sci/R&D Officer Director/Board Member Chief Executive Officer | |
University of Aarhus | College/University | Graduate Degree Doctorate Degree Director/Board Member Graduate Degree Graduate Degree Graduate Degree | |
Technical University of Denmark | College/University | Chairman Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
University of Uppsala | College/University | Doctorate Degree Graduate Degree Doctorate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree | |
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Karolinska Institutet | College/University | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Doctorate Degree Doctorate Degree | |
LEO Pharma A/S
LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
SYNACT PHARMA AB | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer Director/Board Member | |
University of Copenhagen | College/University | Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
Novo Seeds
Novo Seeds Investment ManagersFinance Novo Seeds (Novo Seeds) is a venture capital operating division of Novo Nordisk Fonden. The firm was established in 2007, and is headquartered in Hellerup, Denmark. | Investment Managers | Corporate Officer/Principal Director of Investments Director of Investments Private Equity Investor | |
Royal Swedish Academy of Engineering Sciences
Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Symphogen A/S
Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Moelis & Co. (UK) LLP
Moelis & Co. (UK) LLP Investment Banks/BrokersFinance Part of Moelis & Co., Moelis & Co. (UK) LLP is an independent investment bank that provides confidential and unconflicted strategic advice to clients across various industries. The company is based in London, UK. Leveraging their extensive network of 21 geographic locations, the British company delivers the best solutions to their clients. Mark Jonathan Aedy has been the CEO of the company since 2010. | Investment Banks/Brokers | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Novo Nordisk Fonden
Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Chairman Chairman Director/Board Member | |
Glionova AB
Glionova AB Pharmaceuticals: MajorHealth Technology Glionova AB develops cancer treatment drugs. The firm is a drug discovery and development company. It offers GLN-1001 product. The company was founded by Lars G. J. Hammarström and Patrik Ernfors in 2014 and is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
NTG NORDIC TRANSPORT GROUP A/S | Trucking | Director/Board Member Corporate Officer/Principal Chairman | |
MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Chairman Chief Tech/Sci/R&D Officer | |
SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chairman Chief Executive Officer Chief Tech/Sci/R&D Officer | |
University of Oxford | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
Royal Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree Graduate Degree | |
DANSKE BANK A/S | Major Banks | Director/Board Member Director/Board Member President | |
Active Security Trading AB | Director/Board Member Chairman Director/Board Member | ||
DADES A/S
DADES A/S Real Estate DevelopmentFinance DADES A/S provides real estate investment services. It owns and operates shopping centers, office buildings, and residential properties. The company was founded by Ejnar Danielsen in 1937 and is headquartered in Kongens Lyngby, Denmark. | Real Estate Development | Director/Board Member Director/Board Member Chairman | |
Envirotainer AB
Envirotainer AB Containers/PackagingProcess Industries Envirotainer AB provides cold chain solutions for the pharmaceutical supply chain. It offers active cold chain services, qualification services, shipment set up services, technical support, post-shipment analysis and telemetry solution. The company was founded in 1985 and is headquartered in Sollentuna, Sweden. | Containers/Packaging | Director/Board Member Director/Board Member Director/Board Member | |
Actinova AB | Director/Board Member Director/Board Member Director/Board Member | ||
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Director/Board Member Chief Executive Officer Director/Board Member | |
ORPHAZYME A/S | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member | |
Xellia Pharmaceuticals ApS
Xellia Pharmaceuticals ApS Pharmaceuticals: MajorHealth Technology Xellia Pharmaceuticals ApS manufactures pharmaceutical products. Its products include pharmaceutical ingredients, finished dosage forms and novel anti infective pipeline. The company was founded in 1959 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer Director/Board Member | |
Thesan Pharmaceuticals, Inc.
Thesan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Thesan Pharmaceuticals, Inc. provides novel therapeutics for disorders of the skin. The company focuses on the discovery and development of new chemical entities that provide improved treatment options to patients. Thesan Pharmaceuticals was founded in 2011 by Edward P. Monaghan and is headquartered in Carlsbad, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Carnegie Investment Bank AB
Carnegie Investment Bank AB Investment Banks/BrokersFinance Carnegie Investment Bank AB is the broker/delear subsidiary of Carnegie Holding AB in Sweden. Headquartered in Stockholm, the firm was founded in 1803 and offers institutional clients several services within research, equity sales and equity capital market transactions (ECM). The Fixed Income unit offers bond research and sales. Carnegie Investment Bank’s research and equity sales enjoy a global position in Nordic equities. | Investment Banks/Brokers | Director of Finance/CFO Corporate Officer/Principal | |
COLOPLAST A/S | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
University of Cambridge | College/University | Doctorate Degree Masters Business Admin | |
Outpost Medicine, Inc.
Outpost Medicine, Inc. Pharmaceuticals: MajorHealth Technology Outpost Medicine LLC develops therapeutics for the treatment of urologic and gynecologic disorders. The company was founded by David Socks and Tachi Yamada in 2016 and is headquartered in Lexington, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
NNIT A/S | Information Technology Services | Director/Board Member Director/Board Member | |
EVOTEC SE | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
CONVATEC GROUP PLC | Medical Specialties | Director/Board Member Director/Board Member | |
Reapplix A/S
Reapplix A/S Medical DistributorsDistribution Services Reapplix A/S specializes in the biological treatment and management of diabetic foot ulcers. It develops the LeucoPatch device, which is composed of precision molded medical grade plastic components, that facilitates a processing of autologous blood. The company was founded by Niels Erik Holm and Rasmus Lundquist in 2008 and is headquartered in Birkerod, Denmark. | Medical Distributors | Chairman Director/Board Member |
Statistics
International
Denmark | 23 |
Sweden | 21 |
United Kingdom | 5 |
United States | 4 |
Germany | 2 |
Sectoral
Health Technology | 20 |
Consumer Services | 11 |
Finance | 10 |
Commercial Services | 5 |
Process Industries | 3 |
Operational
Director/Board Member | 520 |
Chairman | 193 |
Corporate Officer/Principal | 135 |
Independent Dir/Board Member | 94 |
Chief Executive Officer | 75 |
Most connected contacts
Insiders | |
---|---|
Birgitta Monica Caneman | 59 |
Eivind Kolding | 50 |
Johan Rutger Christenson | 35 |
Peter Sjöstrand | 35 |
Maria Christina Schauman | 32 |
Alf Gunnar Martin Nicklasson | 31 |
Sten Scheibye | 31 |
Nanna Liebach Lüneborg | 29 |
Karl Peter Thelin | 29 |
Peter Bisgaard | 28 |
Torbjørn Bjerke | 27 |
Samir Kamal | 27 |
Håkan Åström | 26 |
Jeppe Fonager Christiansen | 26 |
Peter Moldt | 25 |
- Stock Market
- Insiders
- Michael Shalmi
- Company connections